| Joaquin Duato |
Mr. Joaquin Duato is a Chairman & Chief Executive Officer at Johnson & Johnson. Mr. Duato was previously employed as an Independent Director by Hess Corp., a President by Ortho Biotech Products LP, a Managing Director by Janssen Cilag SpA, a Chairman by Pharmaceutical Research & Manufacturers of America, and a Trustee by Save The Children Federation Inc. He also served on the board at United States Fund for UNICEF, CEO Roundtable on Cancer, Inc. and U.S.-Spain Council, Inc. He received his graduate degree from Thunderbird School of Global Management and an MBA from Escuela Superior de Administración y Dirección de Empresas. |
| Kristen Blair Mulholland |
Kristen Blair Mulholland is currently Chief Human Resources Officer & Executive VP at Johnson & Johnson, a position held since 2024. Education history includes graduate studies at Case Western Reserve University and undergraduate studies at Tulane University (Louisiana). |
| Kathryn E. Wengel |
Kathryn E. Wengel is currently an Independent Director at Laboratory Corporation of America Holdings since 2021, a Director at GS1 AISBL, an Independent Director at Labcorp Holdings, Inc. since 2024, Chief Technical Operations & Risk Officer at Johnson & Johnson since 2023, and a Member of Associazione Nazionale Produttori Illuminazione. Formerly, Ms. Wengel was Chairman at the National Association of Manufacturers. Ms. Wengel completed undergraduate education at Princeton University. |
| James D. Swanson |
James D. Swanson is Chief Information Officer & Executive VP at Johnson & Johnson since 2022, with employment at Johnson & Johnson starting in 2019. Formerly, Mr. Swanson was Chief Information Officer at Bayer CropScience, Inc. from 2018 to 2019, Director & Chief Information Officer at Monsanto Co. in 2018, Vice President-Information Technology at Merck & Co., Inc. from 2005 to 2013, and held the position of Chief Information Officer & Vice President at Johnson & Johnson Pharmaceutical Group. Education includes undergraduate and graduate degrees from Drexel University. |
| Joseph J. Wolk |
Mr. Joseph J. Wolk, CPA, is an Independent Director at Prudential Financial, Inc., a Chief Financial Officer & Executive Vice President at Johnson & Johnson, a Member at Cnbc Global Cfo Council, a Member at Stanford University School of Medicine and a Member at Wall Street Journal Cfo Network. He is on the Board of Directors at Prudential Financial, Inc. and St. Joseph's University. Mr. Wolk was previously employed as a Chief Financial Officer & Vice President-Finance by Janssen Pharmaceuticals, Inc. He also served on the board at Kenvue, Inc. He received his undergraduate degree from St. Joseph's University and a graduate degree from Temple University Beasley School of Law. |
| Robert J. Decker |
Mr. Robert J. Decker is a Chief Accounting Officer & Controller at Johnson & Johnson. He received his undergraduate degree from Rider University. |
| Elizabeth Forminard |
Elizabeth Forminard is currently Chief Legal Officer & Executive Vice President at Johnson & Johnson, a position held since 2006. Education includes an undergraduate degree from Cornell University and a graduate degree from The University of Pennsylvania Law School. |
| Penny M. Heaton |
Penny M. Heaton currently works at Johnson & Johnson, as Chief Medical Officer from 2024 and Pediatric Infectious Diseases Society, as Member. Dr. Heaton also formerly worked at Merck & Co., Inc., as Director-Vaccines Clinical Research from 1999 to 2006, Novavax, Inc., as Chief Medical Officer from 2006 to 2009, and Centers for Disease Control & Prevention, as Medical Officer. Dr. Heaton received her undergraduate degree from the University of Louisville. |
| Jennifer A. Doudna |
Dr. Jennifer A. Doudna is a Chief Science Advisor at Sixth Street Advisors LLC, an Independent Director at Tempus AI, Inc., an Independent Director at Johnson & Johnson, a Chairman & President at Innovative Genomics Institute, a Professor at University of California, Berkeley, a Chancellor Chair at Li Ka Shing (Canada) Foundation, an iPartner at The Column Group LLC, a Member-Molecular, Cell Biology & Chemistry at American Academy of Arts & Sciences, a Member-Molecular, Cell Biology & Chemistry at Lawrence Berkeley National Laboratory, a Member-Molecular, Cell Biology & Chemistry at National Academy of Sciences and a Scientific Advisory Board at eFFECTOR Therapeutics, Inc. She is on the Board of Directors at Tempus AI, Inc., Johnson & Johnson, Altos Labs, Inc., Driver, Inc. and Pomona College. Dr. Doudna was previously employed as a Co-Founder by Mammoth Biosciences, Inc., a Founder by Editas Medicine, Inc., a Founder by Caribou Biosciences, Inc., a Founder by Intellia Therapeutics, Inc., a Vice President-Discovery Research by Genentech, Inc., a Co-Founder by Aurora Therapeutics, Inc., a Co-Founder by Azalea Therapeutics, Inc., a Member-Molecular, Cell Biology & Chemistry by Howard Hughes Medical Institute, Inc., a Consultant by Merck Ltd., an Advisor by Orchard Venture Partners, a Consultant by Pfizer Inc., a Co-Founder by Scribe Therapeutics, Inc., and a Member by The Royal Society. She received her undergraduate degree from Pomona College and a doctorate degree from Harvard Medical School. |
| John George Morikis |
John George Morikis is currently Chairman at University Hospitals Health System, Inc., Vice Chairman at Joint Center for Housing Studies, Independent Director at General Mills, Inc. (starting 2024), Independent Director at United Parcel Service, Inc. (starting 2025), Director at Greater Cleveland Partnership, Director at University Hospitals Ahuja Medical Center, Independent Director at Johnson & Johnson (starting 2025), Independent Director at Whirlpool Corp. (starting 2025), President at Geocel LLC, and President at Engineered Polymer Solutions, Inc. Former positions include President & Director at The Valspar Corp., Director at Sherwin-Williams Protective & Marine Coatings from 2016 to 2018, Independent Director at Fortune Brands Innovations, Inc. from 2013 to 2024, and Director at The Sherwin-Williams Co. from 2024 to 2025. Education includes graduate studies at National-Louis University and undergraduate studies at Saint Joseph's College (Indiana). |
| Mark Alan Weinberger |
Mr. Mark A. Weinberger is an Independent Director at JPMorgan Chase & Co., an Independent Director at Johnson & Johnson, an Independent Director at MetLife, Inc., an Independent Non-Executive Director at Saudi Arabian Oil Co. and a Member at Aspen Economic Strategy Group. He is on the Board of Directors at JPMorgan Chase & Co., Johnson & Johnson, MetLife, Inc., Saudi Arabian Oil Co., Ernst & Young (Nigeria), JUST Capital Foundation, Inc., MetLife Services & Solutions LLC, National Bureau of Economic Research, Inc., The Bullis School, Inc., The Tax Council, Case Western Reserve University, Emory University, Greater Washington Partnership, The American Council for Capital Formation, The Concord Coalition and United States Council for International Business. Mr. Weinberger was previously employed as an Independent Director by Accelerate Acquisition Corp., an Assistant Secretary by U.S. Department of the Treasury, a Principal by Washington Counsel PC, a Partner by Oldaker, Biden & Belair LLP, a Partner by Ryan Phillips Utrecht & Mackinnon, a Chief Tax & Budget Counsel by United States Senate, a Chairman & Chief Executive Officer by Ernst & Young LLP, a Member-International Business Council by Forum Mondial de L'Economie, a Member by The International Business Council, and a Vice Chairman by The Kennedy Center Corporate Fund. He also served on the board at The Business Roundtable and Catalyst, Inc. He received his undergraduate degree from Emory University, a graduate degree from Case Western Reserve University, a graduate degree from Georgetown University Law Center and an MBA from Case Western Reserve University. |
| Daniel E. Pinto |
Daniel E. Pinto is currently the Chief Executive Officer at JPMorgan Securities Plc (Market-Maker). He holds the position of Vice Chairman at JPMorgan Chase & Co. since 2025. He has been a Director at The Institute of International Finance, Inc. since 2013. Starting in 2025, he is an Independent Director at Johnson & Johnson. Mr. Pinto completed undergraduate studies at Universidad Nacional De Lomas De Zamora. |
| Mary C. Beckerle |
Mary C. Beckerle is currently Chief Executive Officer-Huntsman Cancer Institute at the University of Utah Health Care since 2006 and Chief Executive Officer at Huntsman Cancer Institute since 2006. Other current roles include Independent Director at Johnson & Johnson since 2015, Director at Huntsman International LLC, Independent Director at Exelixis, Inc. since 2024, Director at Coalition For Life Sciences, Member-Cancer Policy at the University of Pennsylvania, Professor at the University of Utah since 2013, Member of the National Academy of Sciences, Member of the American Philosophical Society, Member-Cancer Policy at Duke University School of Medicine, Member-Cancer Policy at Georgetown University Medical Center, Member-Cancer Policy at National Center For Biological Sciences, and Member of the American Academy of Arts & Sciences. Former positions include Chief Executive Officer at National Cancer Institute, Chairman-Council for Extramural Grants at American Cancer Society, Inc., Independent Director at Huntsman Corp. from 2011 to 2026, Director at Howard Hughes Medical Institute, Inc., Director at National Institutes of Health, Director at Huntsman Cancer Foundation from 2015 to 2017, Director at American Association for Cancer Research, and President at The American Society for Cell Biology. Education includes a doctorate from The University of Colorado and an undergraduate degree from Wells College. |
| Mark B. McClellan |
Dr. Mark B. McClellan is an Independent Director at The Cigna Group, a Professor at Duke University, an Independent Director at Alignment Healthcare, Inc., an Independent Director at Johnson & Johnson, a Director & Managing Director at Alignment Healthcare USA LLC, a Member at Dell Medical School, a Member at National Academy of Medicine (United States), a Member at The National Academies of Science, an Operating Partner at CR Group LP and a Senior Advisor at Arsenal Capital Management LP. He is on the Board of Directors at Cigna Holding Co., The Cigna Group, Margolis Center For Health Policy, The Gary & Mary West Health Institute, Alignment Healthcare, Inc., Johnson & Johnson, Alliance For Health Policy, Inc., Aviv Healthcare Properties LP, Long-Term Quality Alliance, National Council on Aging, Inc., PrognomIQ, Inc., Reagan-udall Foundation, Research!America, The National Alliance For Hispanic Health, United States of Care, Alignment Healthcare USA LLC and Arsenal Capital Management LP. He received his undergraduate degree from The University of Texas at Austin, a graduate degree from Harvard Kennedy School of Government, a doctorate degree from Massachusetts Institute of Technology and a doctorate degree from Harvard Mit Health Sciences & Technology. |
| Paula A. Johnson |
Paula A. Johnson is currently an Independent Director at Johnson & Johnson since 2023, Director at The Isabella Stewart Gardner Museum, Inc. and Isabella Stewart Gardner Museum since 2015, President of Wellesley College since 2016, Trustee of The Rockefeller University since 2021, and a Member of the American Academy of Arts & Sciences and the National Academy of Medicine (United States). Formerly, Dr. Johnson was an Independent Director at ABIOMED, Inc. from 2021 to 2022, Independent Director at Eaton Vance Corp. from 2018 to 2021, Independent Director at West Pharmaceutical Services, Inc. from 2005 to 2021, Executive Director-Connors Center at The Brigham & Women's Hospital, Inc. from 2002 to 2016, Associate Professor at Harvard Medical School, and Professor at Harvard T.H. Chan School of Public Health. Education includes a doctorate from Harvard Medical School, undergraduate degree from Radcliffe College, and graduate degree from Harvard T.H. |
| Eugene A. Woods |
Eugene A. Woods is President & Chief Executive Officer at The Charlotte-Mecklenburg Hospital Authority (North Carolina), Carolinas College of Health Sciences, and Atrium Health, Inc. since 2016. Since 2022, holds the positions of Co-Chief Executive Officer at Advocate Health, Inc. and Chief Executive Officer at Advocate Aurora Health, Inc. Since 2023, serves as Independent Director at Johnson & Johnson. Holds director roles at North Carolina Baptist Hospital, Scottsdale Institute, and Wake Forest Baptist Medical Center. Formerly Chief Executive Officer & SVP-Operations at St. Joseph Health System from 2005 to 2011. Served as President & Chief Executive Officer at Roy Lester Schneider Hospital from 1998 to 2001. Chairman of American Hospital Association, Inc. from 2012 to 2017. Chairman at Federal Reserve Bank of Richmond. Independent Director at Best Buy Co., Inc. from 2018 to 2024. Vice President-Administration at Bon Secours Mercy Health Petersburg LLC from 1993 to 1998. President & Chief Operating Officer at CHRISTUS Health, Inc. from 2014 to 2016. Chief Operating Officer & Senior Vice President at Washington Hospital Center Corp. from 2001 to 2005. Educated at The Pennsylvania State University with undergraduate, graduate, and MBAistration degrees. |
| Hubert Joly |
Hubert Joly currently works at Minnesota Business Partnership, Inc., as Vice Chairman, The Business Council, as Vice Chairman, Johnson & Johnson, as Independent Director from 2019, Sciences Po American Foundation, as Director, S&P Global, Inc., as Independent Director from 2026, The New York Public Library Astor Lenox & Tilden Foundations, as Trustee, Minnesota Orchestral Association, as Trustee, and The Minneapolis Society of Fine Arts, as Trustee. Mr. Joly also formerly worked at Vivendi SE, as Chief Executive Officer-Video Game Unit, Carlson, Inc., as President, Chief Executive Officer & Director from 2008 to 2012, CWT US LLC, as Chairman, President & Chief Executive Officer from 2004 to 2008, Radisson Hospitality LLC, as President & Chief Executive Officer, Park Inn Hotels, as President, Chief Executive Officer & Director, CW Travel Holdings NV, as President, Chief Executive Officer & Director, Best Buy Co., Inc., as Executive Chairman from 2019 to 2020, Radisson Hospitality AB, as Vice Chairman in 2012, Retail Industry Leaders Association, as Vice Chairman, World Travel & Tourism Council Ltd., as Director, Ralph Lauren Corp., as Lead Independent Director from 2021 to 2025, Electronic Data Systems Corp., as Vice President-European Region, McKinsey & Co., Inc., as Partner, Vivendi Universal Games, Inc., as Executive VP-American Assets & Deputy CFO from 2002 to 2004, and Electronic Data Systems France SAS, as President & Vice President-Europe from 1996 to 1999. Mr. Joly received his undergraduate degree from Sciences Po and undergraduate degree from École des Hautes Études Commerciales de Paris. |
| Nadja Y. West |
Dr. Nadja Y. West, MD, is an Independent Director at Tempus AI, Inc., an Independent Director at Johnson & Johnson, an Independent Director at Tenet Healthcare Corp. and an Independent Director at Nucor Corp. He is on the Board of Directors at Tempus AI, Inc., Johnson & Johnson, Tenet Healthcare Corp., Nucor Corp., AmeriCares Foundation, Inc., Woodruff Foundation, The National Collegiate Athletic Association, Mount St. Mary's University, Inc. and National Recreation Foundation. Dr. West was previously employed as a Commanding General by U.S. Army Medical Department and a Deputy Chief of Staff by U.S. Army Medical Department. He received his undergraduate degree from US Military Academy, a graduate degree from The National War College and a doctorate degree from George Washington University School of Medicine & Health. |
| Marillyn A. Hewson |
Marillyn A. Hewson currently works at The Business Roundtable, as Vice Chairman, The Kennedy Center Corporate Fund, as Vice Chairman, Chevron Corp., as Independent Director from 2021, and various other companies. Ms. Hewson also formerly worked at Lockheed Martin Ventures, as Chairman, President & CEO from 2014 to 2020, Lockheed Martin Corp., as Executive Chairman from 2020 to 2021, Lockheed Martin Investment Management Co., as Executive Chairman from 2020 to 2022, and various other companies. Ms. Hewson received her undergraduate degree in 1976 from The University of Alabama and graduate degree in 1979 from The University of Alabama. |
